Exploring the Use of Genome Editing, Cell Armouring, & Other Approaches to Mitigate Immunogenicity
Time: 9:30 am
day: Day One
Details:
• Utilising CRISPR technologies to reduce immunogenicity of allogeneic CAR-T therapies
• Combatting T-cell exhaustion to create a sustained and hyper-active antitumoural
therapy
• Assessing shielding technologies to protect allogeneic cells from immune surveillance
